NF-kappa inhibitor containing as the active ingredient phenylmethyl benzoquinone

Details for Australian Patent Application No. 2003244564 (hide)

Owner Daiichi Suntory Pharma Co., Ltd.

Inventors Saitoh, Masayuki; Nunokawa, Yoichi; Suzuki, Kenji

Agent Griffith Hack

Pub. Number AU-B-2003244564

Parent 28543

Filing date 4 September 2003

Wipo publication date 2 October 2003

Acceptance publication date 9 September 2004

International Classifications

A61K 031/12 - Ketones

C07D 319/18 Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 317/66 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 295/30 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 265/30 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 223/10 Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 217/06 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 215/08 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 213/75 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/40 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 211/74 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/62 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/70 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/60 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/58 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/52 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/46 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/42 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/32 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/22 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/16 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 207/04 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07C 235/78 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 066/00 Quinone carboxylic acids

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/54 - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61K 031/535 - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61K 031/44 - Non-condensed pyridines

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/36

A61K 031/335 - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 031/245

A61K 031/19

A61K 031/165 - having aromatic rings, e.g. colchicine, atenolol, progabide

Event Publications

18 September 2003 Complete Application Filed

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2003244564

8 January 2004 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Daiichi Suntory Pharma Co Ltd to Daiichi Suntory Pharma Co., Ltd.

9 September 2004 Application Accepted

  Published as AU-B-2003244564

13 January 2005 Standard Patent Sealed

5 January 2006 Change of Name(s) of Applicant(s), Section 104

  Daiichi Suntory Pharma Co., Ltd. The name of the applicant has been changed to Daiichi Asubio Pharma Co., Ltd.

8 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003244565-Travel potty

2003244563-Screen Retention Arrangement